Hubro Therapeutics

Developer of immunotherapies for cancer treatment

placeOslo, Oslo, Norway calendar_todayFounded 2018 groups5 employees language hubrotherapeutics.com

Registered entities

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 108 times.

YearFilings
20201
20212
20222
20233
20244

Investor mix

3 investors on record; lead investors include Investinor.

Investor typeCountShare
Venture capital3100%
Coming soon